200 related articles for article (PubMed ID: 32120778)
1. Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy.
Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Amir M; Sarafroz M
Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32120778
[TBL] [Abstract][Full Text] [Related]
2. A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment.
Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Buheazah TM; AlHomoud HS; Al-Nasif HA; Alam MA
Saudi J Biol Sci; 2020 Sep; 27(9):2344-2357. PubMed ID: 32884416
[TBL] [Abstract][Full Text] [Related]
3. A bioanalytical UHPLC based method used for the quantification of Thymoquinone-loaded-PLGA-nanoparticles in the treatment of epilepsy.
Ahmad N; Ahmad R; Al Qatifi S; Alessa M; Al Hajji H; Sarafroz M
BMC Chem; 2020 Dec; 14(1):10. PubMed ID: 32083254
[TBL] [Abstract][Full Text] [Related]
4. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment.
Ahmad N; Al-Subaiec AM; Ahmad R; Sharma S; Alam MA; Ashafaq M; Abdur Rub R; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):475-490. PubMed ID: 30739499
[TBL] [Abstract][Full Text] [Related]
5. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
[TBL] [Abstract][Full Text] [Related]
6. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ
Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
[TBL] [Abstract][Full Text] [Related]
7. Preparation of novel S-allyl cysteine chitosan based nanoparticles for use in ischemic brain treatment.
Khan MF; Ahmad N; Alkholifi FK; Ullah Z; Khalid MS; Akhtar S; Farooqui S; Khan N; Chaudhary AA; Alawam AS; Ali MAM
RSC Adv; 2024 Jan; 14(1):160-180. PubMed ID: 38173594
[No Abstract] [Full Text] [Related]
8. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia.
Ahmad N; Ahmad R; Ahmad FJ; Ahmad W; Alam MA; Amir M; Ali A
Saudi J Biol Sci; 2020 Jan; 27(1):500-517. PubMed ID: 31889876
[TBL] [Abstract][Full Text] [Related]
9. Impact of ultrasonication techniques on the preparation of novel Amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S192-S207. PubMed ID: 30032652
[TBL] [Abstract][Full Text] [Related]
10. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
12. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
Haggag YA; Abosalha AK; Tambuwala MM; Osman EY; El-Gizawy SA; Essa EA; Donia AA
Biopharm Drug Dispos; 2021 Jan; 42(1):12-23. PubMed ID: 33320969
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-Coated PLGA Nanoparticles Loaded with
Azzazy HME; Fahmy SA; Mahdy NK; Meselhy MR; Bakowsky U
Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578755
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.
Ahmad N; Ahmad R; Alam MA; Ahmad FJ
Chem Cent J; 2018 May; 12(1):65. PubMed ID: 29796830
[TBL] [Abstract][Full Text] [Related]
16. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
17. A comparative pulmonary pharmacokinetic study of budesonide using polymeric nanoparticles targeted to the lungs in treatment of asthma.
Ahmad N; Ahmad R; Almakhamel MZ; Ansari K; Amir M; Ahmad W; Ali A; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):749-762. PubMed ID: 32272850
[TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
19. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
20. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect.
Anwer MK; Mohammad M; Iqbal M; Ansari MN; Ezzeldin E; Fatima F; Alshahrani SM; Aldawsari MF; Alalaiwe A; Alzahrani AA; Aldayel AM
J Thromb Thrombolysis; 2020 Apr; 49(3):404-412. PubMed ID: 31898270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
